Earnings Feed
Start Free
Home/Filings/4/0001348362-25-000008
4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001348362-25-000008

CIK 0001348362other
View on SEC.govCompany Profile

Filed

May 15, 8:00 PM ET

Accepted

May 16, 5:19 PM ET

Size

13.2 KB

Accession

0001348362-25-000008

Insider Transaction Report

Form 4
Period: 2025-05-15
Lexaria Bioscience Corp.LEXX
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
  • Award

    Stock Options

    2025-05-15+150,000→ 310,834 total
    Exercise: $1.04From: 2025-05-15Exp: 2030-05-15→ Common Shares (150,000 underlying)
Holdings

  • common shares

    (indirect: Private Holding Company)
    54,075

  • Stock Options

    Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (18,000 underlying)
    18,000

  • Stock Options

    Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (18,334 underlying)
    36,334

  • Stock Options

    Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying)
    51,334

  • Stock Options

    Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)
    81,334

  • Stock Options

    Exercise: $1.15From: 2023-10-26Exp: 2028-10-26→ Common Shares (30,000 underlying)
    111,334

  • Stock Options

    Exercise: $2.36From: 2024-04-26Exp: 2029-04-26→ Common Shares (49,500 underlying)
    160,834

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001638727

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 5:19 PM ET
Size
13.2 KB
View on SEC.gov